MeVis Medical Solutions AG (M3V) — Long-term Investment Intensity

Latest as of September 2019: 1.3%

MeVis Medical Solutions AG (M3V) has a Long-term Investment Intensity of 1.3% as of September 2019. Long-term investments of €312.04K represent 1.3% of total assets of €23.92 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of MeVis Medical Solutions AG to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

1.3%
LT Investments / Total Assets

Long-term Investments

€312.04K
EUR

Total Assets

€23.92 Million
EUR

Country

Germany
XETRA

MeVis Medical Solutions AG Long-term Investment Intensity (2014–2019)

This chart shows how MeVis Medical Solutions AG's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 1.3%, reflecting long-term investments of €312.04K against total assets of €23.92 Million EUR. Explore MeVis Medical Solutions AG (M3V) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for MeVis Medical Solutions AG (2014–2019)

The table below presents the year-by-year Long-term Investment Intensity for MeVis Medical Solutions AG from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see M3V market cap.

Year LT Investment Intensity LT Investments (EUR) Total Assets Change (pp)
2019 1.3% €312.04K €23.92 Million ▲ +0.5 pp
2018 0.8% €312.04K €38.42 Million ▼ -3.2 pp
2017 4.1% €1.99 Million €49.08 Million ▲ +0.3 pp
2016 3.7% €1.61 Million €43.00 Million ▼ 0.0 pp
2015 3.8% €1.72 Million €45.55 Million ▼ -0.3 pp
2014 4.1% €1.57 Million €38.25 Million
pp = percentage points